These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14485446)

  • 1. Adjuvant effect of silica (tridymite) on antibody production.
    PERNIS B; PARONETTO F
    Proc Soc Exp Biol Med; 1962 Jun; 110():390-2. PubMed ID: 14485446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on immunity and proteinemia in silicosis. I. Effects of silica on the production of antibodies].
    Szabó S; Csögör S; László I; Adorján E
    Arch Roum Pathol Exp Microbiol; 1967 Sep; 26(3):519-28. PubMed ID: 4298428
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant effects of a crystalline silica on IgE and IgG1 antibody production in mice and their prevention by the macrophage stabilizer poly-2-vinylpyridine N-oxide.
    Mancino D; Buono G; Cusano M; Minucci M
    Int Arch Allergy Appl Immunol; 1983; 71(3):279-81. PubMed ID: 6303964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of adjuvants on the elimination of soluble protein antigens and the associated antibody responses.
    TALMAGE DW; DIXON FJ
    J Infect Dis; 1953; 93(2):176-80. PubMed ID: 13109228
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the enhancing effect of adjuvants on antibody formation in mice.
    HAVAS HF; ANDRE J
    Br J Exp Pathol; 1955 Apr; 36(2):171-4. PubMed ID: 14363579
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a crystalline silica on antibody production to T-dependent and T-independent antigens in Balb/c mice.
    Mancino D; Vuotto ML; Minucci M
    Int Arch Allergy Appl Immunol; 1984; 73(1):10-3. PubMed ID: 6319293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains.
    Mancino D; Ovary Z
    Int Arch Allergy Appl Immunol; 1980; 61(3):253-8. PubMed ID: 6243610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.
    Carvalho LV; Ruiz Rde C; Scaramuzzi K; Marengo EB; Matos JR; Tambourgi DV; Fantini MC; Sant'Anna OA
    Vaccine; 2010 Nov; 28(50):7829-36. PubMed ID: 20937318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant effect of diffusion chambers on soluble antigens.
    ADLER FL; FISHMAN M
    Proc Soc Exp Biol Med; 1962 Dec; 111():691-5. PubMed ID: 14011085
    [No Abstract]   [Full Text] [Related]  

  • 10. FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.
    HERBERT WJ; SELWYN S; PHILP JR
    Br J Prev Soc Med; 1965 Apr; 19(2):97-100. PubMed ID: 14319217
    [No Abstract]   [Full Text] [Related]  

  • 11. A NOVEL METHOD OF ENHANCING ANTIBODY PRODUCTION.
    KING LS
    Southwest Med; 1965 Jul; 46():222-4. PubMed ID: 14342680
    [No Abstract]   [Full Text] [Related]  

  • 12. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE.
    WOODHOUR AF; METZGAR DP; STIM TB; TYTELL AA; HILLEMAN MR
    Proc Soc Exp Biol Med; 1964 Jun; 116():516-23. PubMed ID: 14193390
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant effect of amorphous silica on the immune response to various antigens in guinea pigs.
    Mancino D; Bevilacqua N
    Int Arch Allergy Appl Immunol; 1977; 53(2):97-103. PubMed ID: 191405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE.
    STONE S; HU R; KRUGMAN S; TYTELL AA; HILLEMAN MR
    J Allergy; 1963; 34():420-5. PubMed ID: 14066384
    [No Abstract]   [Full Text] [Related]  

  • 15. [INFLUENCE OF INFLAMMATORY REACTIONS DUE TO KILLED MYCOBACTERIA ON THE TITER OF ANTIBODIES PREVIOUSLY ELABORATED BY GUINEA PIGS AGAINST MUMPS VIRUS].
    HENRY M; SOHIER R; TERRAILLON J
    Rev Immunol Ther Antimicrob; 1964; 28():105-19. PubMed ID: 14232690
    [No Abstract]   [Full Text] [Related]  

  • 16. [IS IT POSSIBLE TO REPLACE ADJUVANT SUBSTANCES IN VACCINES BY COBALT ADMINISTRATION?].
    KATITCH R; STEPHANOVITCH R; DINITCH B; VOUKITCHEVITCH Z; KOSTITCH L
    Rev Immunol Ther Antimicrob; 1964; 28():87-90. PubMed ID: 14187808
    [No Abstract]   [Full Text] [Related]  

  • 17. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrogenic activity of different forms of free silica; the action of fused silica, quartz, cristobalite, and tridymite on the livers of mice.
    ZAIDI SH; KING EJ; HARRISON CV; NAGELSCHMIDT G
    AMA Arch Ind Health; 1956 Feb; 13(2):112-21. PubMed ID: 13282506
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.
    Seth A; Ritchie FK; Wibowo N; Lua LH; Middelberg AP
    PLoS One; 2015; 10(3):e0117203. PubMed ID: 25756283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA.
    HILLEMAN MR; HAMPIL B; SWEET BH
    J Allergy; 1963; 34():413-9. PubMed ID: 14066383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.